miR-134: A Human Cancer Suppressor?
Open Access
- 1 March 2017
- journal article
- review article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 6, 140-149
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81271943)
- Wuhan Municipal Science and Technology Bureau (2015070504020219)
- Fundamental Research Funds for the Central Universities (81372973, 2015305020202, 81360447)
This publication has 111 references indexed in Scilit:
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease ControlsClinical Cancer Research, 2013
- Circulating miRNA profile in HCV infected serum: novel insight into pathogenesisScientific Reports, 2013
- Occupational cancer in BritainBritish Journal of Cancer, 2012
- A Unified Model of Mammalian BCL-2 Protein Family Interactions at the MitochondriaMolecular Cell, 2011
- DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor SurvivalJournal of Biological Chemistry, 2011
- Regulation of mRNA Translation and Stability by microRNAsAnnual Review of Biochemistry, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006